Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Harvard Business School
Mallinckrodt
Dow
Daiichi Sankyo
Cipla
Julphar
Queensland Health
UBS

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,066,755

« Back to Dashboard

Summary for Patent: 4,066,755
Title: Phenylaminoethanol derivatives for treating hypertension
Abstract:Compounds of the formula: ##STR1## and physiologically acceptable acid addition salts thereof, in which R.sup.1 is A. an arylalkyl group, the alkyl portion of which contains from 1 to 6 carbon atoms and the aryl portion of which may be substituted by one or more alkoxy groups or hydroxy groups; or B. an aryloxyalkyl group, the alkyl portion of which contains from 1 to 6 carbon atoms, and the aryloxy portion of which is substituted with one or more alkoxy or hydroxy groups. These compounds have a blacking action on both .alpha.- and .beta.-adrenergic receptors and are useful in treating hypertension. Processes for the production of these compounds and pharmaceutical compositions containing them are also provided.
Inventor(s): Lunts; Lawrence Henry Charles (London, EN), Collin; David Trevor (London, EN)
Assignee: Allen & Hanburys Limited (London, EN)
Application Number:05/753,558
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Dosage form; Delivery;

Drugs Protected by US Patent 4,066,755

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,066,755

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
34379/69Jul 8, 1969

International Family Members for US Patent 4,066,755

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 280996 ➤ Try a Free Trial
Austria 300763 ➤ Try a Free Trial
Belgium 704037 ➤ Try a Free Trial
Belgium 752892 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Moodys
Medtronic
QuintilesIMS
Daiichi Sankyo
Julphar
Citi
Colorcon
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.